MAPT and Alzheimer disease: Levels of tTau and p181-Tau in NEVs of 3xTg-AD mice are elevated compared to other mice types as early as six months, even prior to obvious development of Tau deposition in the cortex, and remain similarly elevated in older mice with fully developed Tau pathology.